These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11140785)

  • 1. Pharmacotherapy of disorders in mental retardation.
    Aman MG; Collier-Crespin A; Lindsay RL
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I98-107. PubMed ID: 11140785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Behavioral disorders and substance abuse in adolescents with mental retardation].
    Papachristou E; Anagnostopoulos D
    Psychiatriki; 2014; 25(2):139-50. PubMed ID: 25035183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation.
    Brasic JR; Barnett JY; Kaplan D; Sheitman BB; Aisemberg P; Lafargue RT; Kowalik S; Clark A; Tsaltas MO; Young JG
    Neurology; 1994 Jul; 44(7):1309-12. PubMed ID: 8035936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a relationship between attention deficit/hyperactivity disorder and manic symptoms among children with mental retardation of unknown etiology?
    Fidan T; Kirpinar I; Oral M; Koçak K
    Compr Psychiatry; 2011; 52(6):644-9. PubMed ID: 21310401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anxiety in children and adolescents with pervasive developmental disorder without mental retardation: review of literature].
    Soussana M; Sunyer B; Pry R; Baghdadli A
    Encephale; 2012 Feb; 38(1):16-24. PubMed ID: 22381719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues.
    Szymanski L; King BH
    J Am Acad Child Adolesc Psychiatry; 1999 Dec; 38(12 Suppl):5S-31S. PubMed ID: 10624083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavior disorders and mental retardation: associations with age, sex, and level of functioning in an outpatient clinic sample.
    Benson BA
    Appl Res Ment Retard; 1985; 6(1):79-85. PubMed ID: 3994360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric disorders in children and adolescents with mental retardation and active epilepsy.
    Steffenburg S; Gillberg C; Steffenburg U
    Arch Neurol; 1996 Sep; 53(9):904-12. PubMed ID: 8815856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECT: use in individuals with mental retardation.
    Friedlander RI; Solomons K
    J ECT; 2002 Mar; 18(1):38-42. PubMed ID: 11925520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin for behavioral dyscontrol with mental retardation.
    Bozikas V; Bascialla F; Yulis P; Savvidou I; Karavatos A
    Am J Psychiatry; 2001 Jun; 158(6):965-6. PubMed ID: 11384914
    [No Abstract]   [Full Text] [Related]  

  • 11. A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders.
    Simeon J; Milin R; Walker S
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):267-75. PubMed ID: 11817503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and prevalence of psychopathology in people with mental retardation.
    Borthwick-Duffy SA
    J Consult Clin Psychol; 1994 Feb; 62(1):17-27. PubMed ID: 8034819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts. Psychopharmacology in children.
    Biederman J; Jellinek MS
    N Engl J Med; 1984 Apr; 310(15):968-72. PubMed ID: 6142421
    [No Abstract]   [Full Text] [Related]  

  • 14. Summary of the Practice Parameters for the Assessment and Treatment of Children, Adolescents, and Adults with Mental Retardation and Comorbid Mental Disorders. American Academy of Child and Adolescent Psychiatry.
    Szymanski L; King BH
    J Am Acad Child Adolesc Psychiatry; 1999 Dec; 38(12):1606-10. PubMed ID: 10596263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacology research for individuals with mental retardation: methodological issues and suggestions.
    Matson JL; Bielecki J; Mayville SB; Matson ML
    Res Dev Disabil; 2003; 24(3):149-57. PubMed ID: 12742384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECT in mental retardation: a review.
    van Waarde JA; Stolker JJ; van der Mast RC
    J ECT; 2001 Dec; 17(4):236-43. PubMed ID: 11731724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of DSM and ICD diagnostic criteria in people with mental retardation. A review of empirical studies.
    Sturmey P
    J Nerv Ment Dis; 1993 Jan; 181(1):38-41. PubMed ID: 8419513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Children with Usher syndrome: mental and behavioral disorders.
    Dammeyer J
    Behav Brain Funct; 2012 Mar; 8():16. PubMed ID: 22449032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of the disorders of mental development in children and adolescents with congenital cyanotic heart defects].
    Kremneva LF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):579-82. PubMed ID: 4705412
    [No Abstract]   [Full Text] [Related]  

  • 20. Professionals' perceptions of psychotropic medication in residential facilities for individuals with mental retardation.
    Singh NN; Ellis CR; Donatelli LS; Williams DE; Ricketts RW; Goza AB; Perlman N; Everly DE; Best AM; Singh YN
    J Intellect Disabil Res; 1996 Feb; 40 ( Pt 1)():1-7. PubMed ID: 8930051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.